Archived explainer. For the current picture see today's OPK page.
Why Is OPKO HEALTH INC (OPK) Stock Up Today?
By the Top Tier Newswire AI Desk · October 15, 2026 at 1:45 PM ET · reviewed against 7 wire stories
OPKO HEALTH INC (OPK) is up +8.76% in the latest session. Our newswire has captured 7 stories on OPK across 6 sources in the last 36 hours, with AI sentiment reading bullish (avg 65/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
OPKO Health shares climbed 8.76% to $1.49 on October 15, 2026. The primary driver was an agreement for Labcorp to acquire select assets from OPKO’s BioReference Health subsidiary. This transaction includes $722 million in cash and up to $150 million in additional earnout payments.
What Happened
Labcorp announced it would acquire more than 80 patient service centers and the FDA-approved 4Kscore Test from BioReference Health. The deal structure provides $722 million in immediate cash, with the potential for an additional $150 million tied to revenue performance. This acquisition expands Labcorp’s access to clinical laboratory services and a broad specialty testing menu for patients and providers nationwide. OPKO Health is effectively shedding its diagnostics businesses through this major divestiture. The company’s stock had already shown momentum in the days leading up to the announcement, reflecting growing market interest in the transaction.
What The Data Shows
The stock opened at $1.35, a 1.2% gap down from the prior close of $1.37, before surging to a session high of $1.87 at 8:10 AM ET. The session low was $1.35 at 7:00 AM ET. Trading volume reached 46.0 million shares, which is 14.5 times the three-month daily average. OPKO Health has a market capitalization of $985.2 million and remains unprofitable, with a trailing twelve-month EPS of negative $0.09. Revenue declined 11.5% over the same period, and the net margin stands at negative 12.4%. The stock has a beta of 1.50 and trades within a 52-week range of $0.98 to $1.75. Over the last eight sessions, the stock moved up 7.7%. The 52-week tape recorded three fresh highs and six fresh lows on October 15, 2026.
What To Watch
Investors will monitor the execution of the BioReference asset sale and its impact on OPKO Health’s remaining business segments. The coverage breadth from multiple financial outlets highlights the significance of this transaction for the company’s future financial structure.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
OPK · today's session (5-min) · +8.76% vs prior close · updated 1:45 PM ETAI sentiment, last 36h · averaged over 7 stories · 65/100 bullish
The headlines behind the move
Story flow · 7 stories on the wire, last 36h · hover or tap a dot for the headline
8h agoMarketChameleonBULLISH 64M&A
OPKO jumps as Labcorp agrees to pay $722 million cash for select BioReference assets and adds the FDA-approved 4Kscore Test
October 15, 2026
OPKO Health shares moved higher after Labcorp announced an agreement to acquire select BioReference Health assets, including more than 80 patient service centers and the FDA-approved 4Kscore Test. The deal includes $722 million in cash at closing (subject to adjustment) and up to $150 million in earnout tied to 4Kscore revenue, with Labcorp forecasting about $250 million of first-year revenue after close.
9h agoInvesting.com MarketsBULLISH 64General
Why is Opko Health stock surging today?
Why is Opko Health stock surging today?
9h agoInvesting.com MarketsBULLISH 74M&A
Opko Health stock soars on $722M BioReference asset sale
Opko Health stock soars on $722M BioReference asset sale
10h agoMarketWatchBULLISH 64M&A
Labcorp Buying Select Assets of OPKO Health's BioReference Health Arm
11h agoSeeking AlphaBULLISH 64M&A
Labcorp to buy select assets of OPKO’s BioReference Health for up to $872M
OPKO Health (OPK) stock jumps as Labcorp (LH) agrees to acquire a portfolio of assets held by its BioReference Health unit for up to $872M. Read more here.
11h agoThe FlyBULLISH 64M&A
Labcorp to acquire laboratory testing assets of Opko Health subsidiary
11h agoPR NewswireBULLISH 64M&A
Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health
Acquisition will expand access to clinical laboratory services, including a broad specialty testing menu for patients and providers nationwide BURLINGTON, N.C. and MIAMI, Fla., Oct. 15, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory...
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →